Combined with the results of in vitro studies on macrophages, the potential mechanism by which rEgAgB ameliorates sepsis-induced hyperinflammatory response may be to shift the M1-like to M2-like phenotype of macrophages through inhibiting TLR2 and MyD88 pathways. Here, MYD88 is linked to Sepsis.